MSB 1.88% $1.05 mesoblast limited

Thanks for sharing@Wilba32I think it important to also reference...

  1. 524 Posts.
    lightbulb Created with Sketch. 139
    Thanks for sharing@Wilba32

    I think it important to also reference Dr Lightner's response to Dr Cheng's letter to the editor re the important role of anti-TNF in treating refractory pCD, suggesting a contributing role of MSCs....

    From Dr Lightner's reply
    "however, by definition, the patients enrolled were refractory to anti-TNF, and their fistulas had not healed despite being on medical therapy. In fact, all patients enrolled had either failed medical therapy or were on stable medical therapy for at least 3 months before study enrollment to minimize any
    confounding with MSC healing."

    Good signs but more work to do

    DYOR

    V




    Reference:
    https://hotcopper.com.au/data/attachments/6130/6130813-fffc85b353415c0e2be642c8ba462686.jpg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.05
Change
-0.020(1.88%)
Mkt cap ! $1.193B
Open High Low Value Volume
$1.08 $1.08 $1.02 $6.417M 6.155M

Buyers (Bids)

No. Vol. Price($)
1 960 $1.04
 

Sellers (Offers)

Price($) Vol. No.
$1.05 25496 3
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
$1.04
  Change
-0.020 ( 2.49 %)
Open High Low Volume
$1.07 $1.08 $1.02 1459083
Last updated 15.59pm 13/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.